Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.


Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.

"Gastroenterology" Том 53, №3, 2019

Back to issue

Features of pharmacotherapy for gastroesophageal reflux disease in pregnant women

Authors: Бреславець Ю.С.
ДУ «Інститут гастроентерології НАМН України», м. Дніпро, Україна

Categories: Gastroenterology

Sections: Specialist manual

print version


Summary

Стаття присвячена проблемі гастроезофагеальної рефлюксної хвороби (ГЕРХ) у вагітних. Висвітлені особливості механізму розвитку ГЕРХ у вагітних. Проаналізовано низку наукових досліджень різних авторів щодо безпеки терапевтичних заходів у зазначеної категорії пацієнток. Автор акцентує увагу на наявності невирішених питань у фармакотерапії ГЕРХ у вагітних.

Статья посвящена проблеме гастроэзофагеальной рефлюксной болезни (ГЭРБ) у беременных. Освещены особенности механизма развития ГЭРБ у беременных. Проанализован ряд научных исследований разных авторов относительно безопасности лечебных мероприятий у данной категории пациенток. Автор акцентирует внимание на наличии нерешенных вопросов в фармакотерапии ГЭРБ у беременных.

The article deals with the problem of gastroesophageal reflux disease in pregnant women. The peculiarities of the mechanism of developing this disease in pregnant women are highlighted. A number of scientific studies of different authors on the safety of therapeutic measures in this category of patients have been analyzed. The author focuses on the presence of unresolved issues in pharmacotherapy for gastroesophageal reflux disease in pregnant women.


Keywords

гастроезофагеальна рефлюксна хвороба; вагітність; патогенез; лікування; огляд

гастроэзофагеальная рефлюксная болезнь; беременность; патогенез; лечение; обзор

gastroesophageal reflux disease; pregnancy; pathogenesis; treatment; review


For the full article you need to subscribe to the magazine.


Bibliography

1. WGO Practice Guideline-Gastroesophageal Reflux Disease (GERD). [Internet]. Available from: http://www.worldgastroenterology.org/guidelines/global-guidelines/gastroesophageal-reflux-disease.

2. El-Serag H.B., Sweet S., Winchester C.C., Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014. № 63. P. 871-880. [Internet]. Available from: doi: 10.1136/gutjnl-2012-304269

3. Habr F., Raker C., Lin C.L., Zouein E., Bourjeily G. Predictors of gastroesophageal reflux symptoms in pregnant women screened for sleep disordered breathing: a secondary analysis. Clinics and Research in Hepatology and Gastroenterology. 2013. № 37. P. 93-99.

4. Herregods T.V., Bredenoord A.J., Smout A.J. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Neurogastroenterology & Motility. 2015. № 27(9). P. 1202-13. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26053301 doi: 10.1111/nmo.12611

5. Ramya R.S., Jayanthi N., Alexander P.C., Vijaya S. et al. Gastroesophageal reflux disease in pregnancy: a longitudinal study. Tropical Gastroenterology. 2014. № 35(3). P. 168-172. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/26012321

6. Heidelbaugh J.J. Gastroesophageal Reflux Disease (GERD). Ambulatory Clinical Guidelines Oversight. 2018. [Internet]. Available from: https://www.med.umich.edu/1info/FHP/practiceguides/gerd/gerd.12.pdf.

7. Зайдиева З.С., Прозоров В.В. Гастроэзофагеальная рефлюксная болезнь у беременных: патогенез, клиника, профилактика, лечение. РМЖ. 2010. Т. 18, № 19. С. 1199-203.

8. Rayner C. Dealing with gastroesophageal reflux disease during pregnancy. Medicine Today. 2005. № 6. P. 65-66.

9. Turan I., Kitapcioglu G., Tavmergen Goker E., Sahin G. et al. In vitro fertilization-induced pregnancies predispose to gastroesophageal reflux disease. United European Gastroenterology Journal. 2015. № 4(2). P. 221-228. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804367/doi: 10.1177/2050640615597836.

10. Goral V. Ideal Approach to Gastroesophageal Reflux in Pregnancy. M. J. Gast. 2018. № 3(1). P. 11. [Internet]. Available from: https://www.mathewsopenaccess.com/scholarly-articles/ideal-approach-to-gastroesophageal-reflux-in-pregnancy.pdf. ISSN:2572-6471.

11. Щербинина М.Б., Луговская Т.В., Иванченко Н.А. Изжога беременных: причины и возможности улучшения качества жизни женщин в этот период. Здоровье женщины. 2016. № 2(108). С. 80-86.

12. Malferttheiner S.F., Malfertheiner M.V., Kropf S., Costa S.Det alA prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy. BMC Gastroenterol. 2012. № 12. P. 131. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499455/ doi: 10.1186/1471-230X-12-131.

13. Wu J.C. Gastroesophageal reflux disease: an Asian perspective. Journal of Gastroenterology and Hepatology 2008. № 23(12). P. 785-93. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19120871 doi: 10.1111/j.1440-1746.2008.05684.x.

14. Шехтман М.М., Коротько Г.Ф., Бурков С.Г. Физиология и патология органов пищеварения у беременных. ТашкентМедицина, 1989. 158 с.

15. MacFarlane B. Management of gastroesophageal reflux disease in adults: a pharmacist’s perspective. Integrated Pharmacy Research and Practice. 2018. № 7. P. 41-52. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29892570 doi: 10.2147/IPRP.S142932.

16. Грищенко В.И., Щербина Н.А., О.П. и др. Течение беременности и родов при экстрагенитальных заболеваниях. Харьков, 1992. 191 с

17. Fajer A.B., Holzbauer M., Newport H.M. The contribution of the adrenal gland to the total amount of progesterone produced in the female rat. J. Physiol. [Internet]. 1971. № 214(1). P. 115-126. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1331825/ PMID:5575348

18. Adam M.P., Polifka J.E., Friedman J.M. Evolving knowledge of the teratogenicity of medications in human pregnancy. Am. J. Med. Genet. 2011. № 157. P. 175-82. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21766440 doi: 10.1002/ajmg.c.30313.

19. Dolk H., Loane M., Teljeur C., Densem J. et al. Detection and investigation of temporal clusters of congenital anomaly in Europe: seven years of experience of the EUROCAT surveillance system. European Journal of Epidemiology. 2015. № 30. P. 11531-64. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684832/ doi: 10.1007/s10654-015-0012-y.

20. Nordeng H., Ystrøm E., Einarson A. Perception of risk regarding the use of medications and other exposures during pregnancy. Eur. J. Clin. Pharmacol. 2010. № 66. P. 207-14.

21. Vanessa D.J., Jéssica S.G., Flávia L., Fernanda R.G., Victor V.L. Evaluation of drug prescriptions for pregnant women in the Legal Amazon Region. Revista Brasileira de Saúde Materno Infantil. 2018. № 18. P. 4. [Internet]. Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1519-38292018000400735

22. FDA News Release. FDA issues final rule on changes to pregnancy and lactation labeling information for prescription drug and biological products. Accessed August 1, 2019. [Internet]. Available from: https://www.fda.gov/drugs/labeling/pregnancy-and-lactation-labeling-drugs-final-rule

23. FDA Consumer Articles. Pregnant? Breastfeeding? Better Drug Information Is Coming. Accessed August 1, 2019. [Internet]. Available from: https://www.fda.gov/consumers/consumer-updates/pregnant-breastfeeding-better-drug-information-coming

24. Mospan C. New Prescription Labeling Requirements for the Use of Medications in Pregnancy and Lactation. CE for Pharmacists. The Ohio Pharmacist Foundation. Accessed August 1, 2019. [Internet]. Available from: https://cdn.ymaws.com/www.wsparx.org/resource/resmgr/CE_Magazine/WA_0416_State_CE_Lesson.pdf

25. Shi S., Klotz U. Proton pump inhibitors: an update of their clinical use and pharmacokinetics. J. Clin. Pharmacol. 2008. № 64. P. 935-951. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18679668 doi: 10.1007/s00228-008-0538-y.

26. Australian government: Therapeutic Goods Administration [Internet]. Available from: https://www.tga.gov.au/prescribing-medicines-pregnancy-database

27. Категорії лікарських засобів для застосування у вагітних, 2019. [Internet]. Available from: https://uk.wikipedia.org/wiki/

28. Quartarone G. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents. Minerva Ginecol. 2013. № 65(5). P. 541-549. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/24096290

29. Tygat G.N., McColl K., Tack J., Holtmann G. et al. New algorithm for the treatment of gastro-oesophageal reflux disease. Aliment. Pharmacol. Ther. 2008. № 27(3). P. 249-256. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/17973975

30. Richter JE. Review article: the management of heartburn in pregnancy. Aliment. Pharmacol. Ther. 2005. № 22. P. 749-757. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/16225482 doi:10.1111/j.1365-2036.2005.02654.x

31. Ruigomez A., Garcia Rodriguez L.A., Cattaruzzi C. et al. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am. J. Epidemiol. 1999. № 150. P. 476-481. [Internet]. Available from: htps://www.ncbi.nlm.nih.gov/pubmed/10472947 doi:10.1093/oxfordjournals.aje.a010036

32. Berkovitch M., Elbirt D., Addis A., Schuler-Faccini L., Ornoy A. Fetal effects of metoclopramide therapy for nausea and vomiting of pregnancy. N. Engl. J. Med. 2000. № 343. P. 445-46. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/10939907 doi: 10.1056/NEJM200008103430616

33. Briggs G.G., Freeman R.Y., Yaffe S.J. Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk. Baltimore, USA: William and Wilkins, 2002. Obstet Med. 2009. № 2(2). P. 89. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989726/doi: 10.1258/om.2009.090002

34. Matok I., Gorodischer R., Koren G., Sheiner E. et al. The safety of metoclopramide use in the first trimester of pregnancy. N. Engl. J. Med. 2009. № 360. P. 2528-35. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19516033 doi: 10.1056/NEJMoa0807154.

35. Sachs G., Shin J.M., Howden C.W. The clinical pharmacology of proton pump inhibitors. Alimentary Pharmacology and Therapeutics. 2006. № 23. P. 2-8. [Internet]. Available from: https://uthsc.pure.elsevier.com/en/publications/review-article-the-clinical-pharmacology-of-proton-pump-inhibitor doi:10.1111/j.1365-2036.2006. 02943.x.

36. Dağlı Ü., Kalkan İ.H. Treatment of reflux disease during pregnancy and lactation. Turk. J. Gastroenterol. 2017. № 28 (Suppl. 1). P. 53-56. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/29199169 doi: 10.5152/tjg.2017.14.

37. Pasternak B., Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. The New England journal of medicine. 2010. № 363(22). P. 2114-2123. [Internet]. Available from: https://www.nejm.org/doi/full/10.1056/NEJMoa1002689 doi: 10.1056/NEJMoa1002689

38. Gerson L. Proton pump inhibitors and pregnancy safety // Gastroenterology. 2011. № 141. P. 389-391. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/21620838 doi: 10.1053/j.gastro.2011.05.017

39. Gill S.K., O'Brien L., Einarson T.R., Koren G. Safety of proton pump inhibitors (PPIs) during pregnancy: a meta-analysis. Am. J. Gastroenterol. 2009. № 104. P. 1541-45. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/19491869 doi: 10.1038/ajg.2009.122.

40. Keller J., Frederking D., Layer P. The spectrum and treatment of gastrointestinal disorders during pregnancy. Nat. Clin. Pract. Gastroenterol. Hepatol. 2008. № 5. P. 430-43. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pubmed/18670442 doi: 10.1038/ncpgasthep1197.

41. Habr F., Raker C., Lin C.L., Zouein E., Bourjeily G. Predictors of gastroesophageal reflux symptoms in pregnant women screened for sleep disordered breathing: a secondary analysis. Clin. Res. Hepatol. Gastroenterol. 2013. № 37. P. 93-99. [Internet]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416385/ doi: 10.5223/pghn.2019.22.2.107


Back to issue